| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |